Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

OCUCLEAR

OXYMETAZOLINE HYDROCHLORIDE

Standard Dose
0.025%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview OCUCLEAR is listed in Drugs@FDA under application 018471 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient OXYMETAZOLINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.025% Sponsor BAYER HEALTHCARE LLC Submission history Latest submission status date: 2001-06-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview OCUCLEAR is listed in Drugs@FDA under application 018471 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient OXYMETAZOLINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.025% Sponsor BAYER HEALTHCARE LLC Submission history Latest submission status date: 2001-06-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.